{
    "organizations": [],
    "uuid": "a50672b103268e268b9b7f2f0a47851a265acb1c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cytrx-corp-announces-its-entry-int/brief-cytrx-corp-announces-its-entry-into-a-definitive-agreement-with-destum-partners-idUSFWN1QI14O",
    "ord_in_thread": 0,
    "title": "BRIEF-Cytrx Corp Announces Its Entry Into A Definitive Agreement With Destum Partners",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 28 (Reuters) - Cytrx Corp:\n* CYTRX CORP - ANNOUNCED ITS ENTRY INTO A DEFINITIVE AGREEMENT WITH DESTUM PARTNERS\n* CYTRX - ‍ DESTUM WILL BE EXCLUSIVE ADVISOR FOR IDENTIFICATION OF PARTNERSHIP OPPORTUNITIES FOR CO‘S LADR ULTRA-HIGH POTENCY DRUG CONJUGATES​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-28T22:27:00.000+02:00",
    "crawled": "2018-03-01T21:04:39.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "cytrx",
        "corp",
        "cytrx",
        "corp",
        "announced",
        "entry",
        "definitive",
        "agreement",
        "destum",
        "partner",
        "cytrx",
        "destum",
        "exclusive",
        "advisor",
        "identification",
        "partnership",
        "opportunity",
        "co",
        "ladr",
        "potency",
        "drug",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}